A Pilot Clinical Trial of Varenicline as a Treatment for Alcohol Dependence
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
Purpose: This is an outpatient, randomized, double-blinded, placebo-controlled study in which
either varenicline (twice daily) or placebo will be administered over a 12 week study period
to examine genetic influences on treatment response to varenicline for reduction of hazardous
drinking.
Phase:
N/A
Details
Lead Sponsor:
University of California, San Francisco
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)